Pakistan Acts To Harmonize Disclosure Of Pharma Payments To Doctors

Pakistan’s drug regulator has come up with a strategy to ensure uniformity in how pharma and medical device companies disclose the money they spend on doctors and medical institutes under new ethical marketing rules.

Team of doctors and businesswoman having a meeting in medical office
Pakistan Wants To Improve Transparency On Interactions Between Drug & Device Companies And Health Care Professionals • Source: Shutterstock

The Drug Regulatory Authority of Pakistan is taking steps to ensure that drug and medical device companies follow a harmonized approach when it comes to disclosing the expenses they incur every year as part of their product marketing activities involving health care professionals and medical institutes.

Companies are required to make such disclosures to the DRAP and relevant tax authorities under the “Ethical Marketing to Healthcare Professionals (EMHP) Rules,” which came into force in November 2021

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Pink Sheet

EU Shaping Biotech Act To Unleash SME Potential

 

European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.

New EU Filings

 

Brensocatib, Insmed's investigational treatment for non-cystic fibrosis bronchiectasis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By 

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.